E
Einstein Francisco Camargos
Researcher at University of Brasília
Publications - 58
Citations - 652
Einstein Francisco Camargos is an academic researcher from University of Brasília. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 10, co-authored 52 publications receiving 458 citations.
Papers
More filters
Journal ArticleDOI
Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study.
Einstein Francisco Camargos,Luciana L. Louzada,Juliana Lima Quintas,Janeth de Oliveira Silva Naves,Fernando Mazzilli Louzada,Otávio de Toledo Nóbrega +5 more
TL;DR: This study shows significant therapeutic effects of trazodone 50 mg in community-dwelling AD patients with SD, and shows no differences in frequency or severity rating of adverse events between the groups.
Journal ArticleDOI
Wrist actigraphy for measuring sleep in intervention studies with Alzheimer's disease patients: application, usefulness, and challenges.
TL;DR: The analyses suggest that the methods used in intervention studies encompassing sleep disorders and dementia could be improved by increasing accuracy of diagnosis, categorization of sleep disturbances, adherence to actigraphy, and by clearly defining the variables and endpoints in each study.
Journal ArticleDOI
Underdiagnosis of delirium in the elderly in acute care hospital settings: lessons not learned
Simone Rios Fonseca Ritter,Anne Freitas Cardoso,Marina Machado Pereira Lins,Thayana Louize Vicentini Zoccoli,Marco Polo Dias Freitas,Einstein Francisco Camargos +5 more
TL;DR: This study aimed to estimate the prevalence, diagnostic accuracy and factors associated with the onset of delirium in the elderly admitted to an urgency unit.
Journal ArticleDOI
Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study.
Francisca Magalhães Scoralick,Luciana L. Louzada,Juliana Lima Quintas,Janeth de Oliveira Silva Naves,Einstein Francisco Camargos,Otávio de Toledo Nóbrega +5 more
TL;DR: The aim of this study was to test the efficacy and safety of mirtazapine in the treatment of sleep disorders in patients with Alzheimer's disease by means of a randomized, double‐blind, placebo‐controlled trial.
Journal ArticleDOI
Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
Adriane Dallanora Henriques,Andrea Lessa Benedet,Einstein Francisco Camargos,Pedro Rosa-Neto,Otávio de Toledo Nóbrega +4 more
TL;DR: The view point of a scenario that places CSF and imaging markers on the verge of general utility based on accuracy levels that already match (or even surpass) current clinical precision is presented.